The biotech sector uses climate change as an urgent argument for more funding and fewer regulatory hurdles. But the urgency of climate change raises the risk of superficial claims and actions.
New developments in organ transplants from animals show promise. However, there has been no public engagement about a potential risk. It may streamline a pathway to humans for new zoonotic diseases.
GM proponents say the technology leads to better crop yields and may solve food shortages and reduce pests. Opponents say GM is a threat to the environment and humans. So where does the truth lie?
South Australia has lifted its moratorium on GM crops, while Tasmania has extended its ban. But the question should no longer be a simple binary of being “for” or “against” GM technology.
Mosquitoes love sugar – so much so that can delay their search for our blood. Now, their sweet tooth may have revealed an important genetic weapon against the spread of mosquito-borne disease.
Synthetic biology is highly promising – but if we don’t get the regulation and engagement right, we risk alienating members of the public, and may even close doors for potentially fruitful research.
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford